RayzeBio (RYZB) Depreciation And Amortization

Annual D&A

N/A

September 1, 2023

Summary

Performance

1-Year Change

-

3-Year Change

-

5-Year Change

-

15-Year Change

-

RYZB Depreciation And Amortization Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$1.53 M
RYZB annual depreciation & amortization is currently at an all-time high

3-Year Low

$455.00 K
RYZB annual depreciation & amortization is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Sep 1, 2023
RYZB previous annual earnings announcement was published on Sep 1, 2023

Next Annual Earnings Report Date

N/A
RYZB next annual earnings announcement has not yet been scheduled

Related metrics

Annual Total Expenses

$2.89 B
RYZB annual total expenses is $2.89 billion

Annual Operating Expenses

$899.60 M
RYZB annual total operating expenses is $899.60 million

Annual Cost Of Goods Sold

$1.99 B
RYZB annual cost of goods sold is $1.99 billion

Annual Interest Expense

$127.00 M
RYZB annual interest expense is $127.00 million

Quarterly D&A

$1.42 M
NaN%

September 30, 2023

Summary

Performance

3-Month Change

-

1-Year Change

+27.79%

3-Year Change

+27.79%

5-Year Change

+27.79%

RYZB Quarterly D&A Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$1.42 M
RYZB quarterly depreciation & amortization is currently at an all-time high

3-Year Low

$1.11 M
RYZB quarterly depreciation & amortization is currently +27.79% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2023
RYZB previous earnings announcement was published on Sep 30, 2023

Next Quarterly Earnings Report Date

N/A
RYZB next earnings announcement has not yet been scheduled

Related metrics

Quarterly Total Expenses

$21.65 M
RYZB quarterly total expenses is $21.65 million

Quarterly Operating Expenses

$21.65 M
RYZB quarterly total operating expenses is $21.65 million

Quarterly Cost Of Goods Sold

-
RYZB quarterly cost of goods sold value is unknown

Quarterly Interest Expense

-
RYZB quarterly interest expense value is unknown

TTM D&A

$1.42 M
NaN%

September 30, 2023

Summary

Performance

3-Month Change

-

1-Year Change

+27.79%

3-Year Change

+27.79%

5-Year Change

+27.79%

RYZB TTM D&A Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$1.42 M
RYZB TTM depreciation & amortization is currently at an all-time high

3-Year Low

$1.11 M
RYZB TTM depreciation & amortization is currently +27.79% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2023
RYZB previous earnings announcement was published on Sep 30, 2023

Next Quarterly Earnings Report Date

N/A
RYZB next earnings announcement has not yet been scheduled

Related metrics

Annual Total Expenses

$2.89 B
RYZB annual total expenses is $2.89 billion

Annual Operating Expenses

$899.60 M
RYZB annual total operating expenses is $899.60 million

TTM Cost Of Goods Sold

-
RYZB TTM cost of goods sold value is unknown

TTM Interest Expense

-
RYZB TTM interest expense value is unknown

RYZB Depreciation And Amortization Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-+27.8%+27.8%
3 y3 years-+27.8%+27.8%
5 y5 years-+27.8%+27.8%

RYZB Depreciation And Amortization Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high-21.7%at high-21.7%
5 y5-yearat high-21.7%at high-21.7%
alltimeall timeat high-21.7%at high-21.7%

RayzeBio Depreciation And Amortization History

DateAnnualQuarterlyTTM
Sep 2023
-
$1.42 M(+27.8%)
$1.42 M(+27.8%)
Dec 2022
$1.53 M
-
-
DateAnnualQuarterlyTTM
Sep 2022
-
$1.11 M
$1.11 M
Dec 2021
$455.00 K(+113.6%)
-
-
Dec 2020
$213.00 K
-
-

FAQ

  • What is the all time high annual D&A for RayzeBio?
  • What is RayzeBio quarterly depreciation & amortization?
  • What is the all time high quarterly D&A for RayzeBio?
  • What is RayzeBio quarterly D&A year-on-year change?
  • What is RayzeBio TTM depreciation & amortization?
  • What is the all time high TTM D&A for RayzeBio?
  • What is RayzeBio TTM D&A year-on-year change?

What is the all time high annual D&A for RayzeBio?

RayzeBio all-time high annual depreciation & amortization is $1.53 M

What is RayzeBio quarterly depreciation & amortization?

The current quarterly D&A of RYZB is $1.42 M

What is the all time high quarterly D&A for RayzeBio?

RayzeBio all-time high quarterly depreciation & amortization is $1.42 M

What is RayzeBio quarterly D&A year-on-year change?

Over the past year, RYZB quarterly depreciation & amortization has changed by +$309.00 K (+27.79%)

What is RayzeBio TTM depreciation & amortization?

The current TTM D&A of RYZB is $1.42 M

What is the all time high TTM D&A for RayzeBio?

RayzeBio all-time high TTM depreciation & amortization is $1.42 M

What is RayzeBio TTM D&A year-on-year change?

Over the past year, RYZB TTM depreciation & amortization has changed by +$309.00 K (+27.79%)